Clinical Role - Specialty Pharmacy

Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.

How biologics have changed clinical practice over conventional chemotherapies and currently available biosimilars in the US.
Pharmacists working collaboratively can make an impact, including for patients with more acute diseases.
Genomic profiles measured through circulating free DNA in the blood of patients with breast cancer may provide a more effective way to treat the disease and track its progression.
Researchers examine how stem cells promote neuronal growth in tissue regeneration and in cancer progression.
Further, these natural killer (NK) cells appear to be more effective the earlier they are in development, creating the possibility of an immunotherapy that would not use cells from a patient or a matched donor.
The American College of Rheumatology addresses the prior authorization requirement for some prescription medications, highlighting the significant burden this creates for patients and rheumatology professionals.
The researchers plan to present updated data at the European Society for Medical Oncology Breast Cancer conference in May.
Small cell lung cancer is highly aggressive and fast-growing, typically recurring and progressing rapidly despite the initial response to chemotherapy.
A recent study conducted by Ohio State University suggests that even organized efforts to clean surfaces can fall short, requiring extra cleaning to be done on a daily basis, especially to fight the spread of coronavirus disease 2019 (COVID-19).
A review of the impact of biosimilars on cancer treatment.
New information from the IQVIA “Global Medicine Spending and Usage Trends” report highlights the expected growth of specialty pharmacy spending by 2024.
DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct but have not spread to other tissues in the breast.